NDC 60219-1410

APREMILAST

Apremilast

APREMILAST is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Ny Llc. The primary component is Apremilast.

Product ID60219-1410_ee9b2224-736a-4dd1-8e8f-6795bf73300e
NDC60219-1410
Product TypeHuman Prescription Drug
Proprietary NameAPREMILAST
Generic NameApremilast
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2021-07-05
Marketing CategoryANDA /
Application NumberANDA211782
Labeler NameAmneal Pharmaceuticals NY LLC
Substance NameAPREMILAST
Active Ingredient Strength30 mg/1
Pharm ClassesPhosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 60219-1410-6

60 TABLET, FILM COATED in 1 BOTTLE (60219-1410-6)
Marketing Start Date2021-07-05
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "APREMILAST" or generic name "Apremilast"

NDCBrand NameGeneric Name
60219-1410APREMILASTAPREMILAST
60219-1744APREMILASTAPREMILAST
55513-137Otezlaapremilast
55513-369Otezlaapremilast
55513-485Otezlaapremilast
59572-630OTEZLAapremilast
59572-631OTEZLAapremilast
59572-632OTEZLAapremilast
70518-3155Otezlaapremilast

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.